Role of Nanocarriers in Management of Non-Hodgkin Lymphoma
- 1st Edition - June 1, 2026
- Latest edition
- Editors: Bhupendra G. Prajapati, Devesh U. Kapoor
- Language: English
Role of Nanocarriers in Management of Non-Hodgkin Lymphoma is a pivotal resource that explores the transformative impact of nanotechnology on the diagnosis, treatment, and manage… Read more
Role of Nanocarriers in Management of Non-Hodgkin Lymphoma is a pivotal resource that explores the transformative impact of nanotechnology on the diagnosis, treatment, and management of non-Hodgkin’s lymphoma (NHL). This comprehensive guide bridges the gap between innovative research and clinical application, focusing on advancements in polymeric nanoparticles, lipid carriers, carbon nanotubes, and immunotherapy approaches. The book provides an in-depth analysis of current technologies and future directions in integrating nanocarriers into NHL management. Each chapter offers evidence-based insights and mechanisms of action, emphasizing the synergy between immunotherapy, precision medicine, and nanotechnology. This resource benefits its academic audience by equipping healthcare professionals with innovative strategies to improve treatment outcomes and inspiring researchers to explore novel therapeutic pathways. By fostering interdisciplinary collaboration among oncologists, pharmaceutical developers, and nanotechnology experts, the book ultimately guides future research to enhance patient care in the rapidly evolving field of non-Hodgkin’s lymphoma management.
- Offers in-depth analyses of various nanocarriers and therapeutic approaches, detailing their mechanisms of action and future potential in non-Hodgkin lymphoma management
- Emphasizes cutting-edge, individualized therapeutic strategies, highlighting innovative treatments like CAR T-cell therapy and mRNA approaches that are crucial for personalized patient care
- Includes practical chapters that address combination therapies and holistic patient care strategies, ensuring that healthcare professionals can effectively implement the latest advancements in their clinical practice
Researchers, academics and post-graduate students in oncology, hematology, pharmacology, and biomedical engineering
1. Introduction to Non-Hodgkin’s Disease and Conventional Therapies
2. Immune Checkpoint Inhibitors in Non-Hodgkin’s Lymphoma Management
3. Exploring Polymeric Nanoparticles in Non-Hodgkin’s Lymphoma Management
4. Magnetic Nanoparticles in Non-Hodgkin’s Lymphoma Therapy: Advancements and Future Directions
5. Leveraging Nanostructured Lipid Carrier (NLCs) in Non-Hodgkin’s Lymphoma Management
6. Breakthrough in Antibody-Drug Conjugates for Non-Hodgkin’s Lymphoma Management
7. Targeted Non-Hodgkin’s Lymphoma Management with Carbon Nanotubes: Potential and Progress
8. Advancement in Non-Hodgkin’s Lymphoma Management Using Exosomes
9. Biological and Immunological Aspects of Vaccines for Non-Hodgkin’s Lymphoma Management
10. Immunotherapy and Radioimmunotherapy Approaches for Non-Hodgkin’s Lymphoma Management
11. Innovative mRNA Approach for Non-Hodgkin’s Lymphoma Management
12. Monoclonal Antibody and CAR T-Cell Therapy: A Novel Avenue in Non-Hodgkin’s Lymphoma Management
13. Combination of Nanocarrier with Chemotherapy for Non-Hodgkin’s Lymphoma Management
14. Patient Care in Non-Hodgkin’s Lymphoma Management
15. Regulatory Challenges and Approvals for Nanocarrier-Based Therapies
2. Immune Checkpoint Inhibitors in Non-Hodgkin’s Lymphoma Management
3. Exploring Polymeric Nanoparticles in Non-Hodgkin’s Lymphoma Management
4. Magnetic Nanoparticles in Non-Hodgkin’s Lymphoma Therapy: Advancements and Future Directions
5. Leveraging Nanostructured Lipid Carrier (NLCs) in Non-Hodgkin’s Lymphoma Management
6. Breakthrough in Antibody-Drug Conjugates for Non-Hodgkin’s Lymphoma Management
7. Targeted Non-Hodgkin’s Lymphoma Management with Carbon Nanotubes: Potential and Progress
8. Advancement in Non-Hodgkin’s Lymphoma Management Using Exosomes
9. Biological and Immunological Aspects of Vaccines for Non-Hodgkin’s Lymphoma Management
10. Immunotherapy and Radioimmunotherapy Approaches for Non-Hodgkin’s Lymphoma Management
11. Innovative mRNA Approach for Non-Hodgkin’s Lymphoma Management
12. Monoclonal Antibody and CAR T-Cell Therapy: A Novel Avenue in Non-Hodgkin’s Lymphoma Management
13. Combination of Nanocarrier with Chemotherapy for Non-Hodgkin’s Lymphoma Management
14. Patient Care in Non-Hodgkin’s Lymphoma Management
15. Regulatory Challenges and Approvals for Nanocarrier-Based Therapies
- Edition: 1
- Latest edition
- Published: June 1, 2026
- Language: English
BP
Bhupendra G. Prajapati
Dr. Bhupendra Gopalbhai Prajapati is a Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India. He is also acting as Adjunct Professor at Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Thailand. With over 22 years of experience in academia, research, and industry, he specializes in lipid-based formulations, nano/microparticulate drug delivery, and bioavailability enhancement. A recipient of several prestigious awards including the AICTE Young Teacher Award and Ganpat University's Staff Excellence honors, Dr. Prajapati has published over 350 research/review papers, and has contributed to more than 170 book chapters. He actively mentors Ph.D. and PG scholars and serves as editor or section editor for several international publications in pharmaceutical sciences.
Affiliations and expertise
Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, IndiaDK
Devesh U. Kapoor
Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. He earned his Ph.D. in Pharmaceutical Sciences in 2013 and has over 20 years of academic experience. Dr. Kapoor has published 175+ research and review articles and contributed 50 book chapters. He is currently editing 18 international books with leading publishers and supervises four Ph.D. students in nanodrug delivery and modified release systems. His editorial roles include Associate Editor for Naunyn-Schmiedeberg’s Archives of Pharmacology, PLOS ONE, and several Frontiers journals, and Consulting Editor for Cytotechnology. He has reviewed manuscripts for 135+ journals and holds eight design patents. Dr. Kapoor has secured research and event grants from GUJCOST, GSBTM, and AICTE-ATAL, delivered 20+ invited talks, and actively participates in national conferences and workshops.
.
Affiliations and expertise
Professor, Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, India